Analyst: Medtronic leadership changes could mean new acquisitions

03/5/2007 | Forbes

Medtronic's shuffling of its top executives could signal new acquisitions for the company but won't likely cause any major shifts in the company's strategic positioning, Goldman Sachs analyst Lawrence Keusch said. Another analyst said the company has "significant growth opportunities in the cardiac stent, diabetes care, spinal surgery and neurology units."

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC